HEART FAILURE WITH RELAPSING ATRIAL FIBRILLATION: BELOW THE SURFACE
Anno:
2024
Advances in pharmacologic and device therapy have greatly improved prognosis of patients with HFrEF. However, the typical clinical course is still characterized by recurring symptoms, worsening functional status and risk of frequent hospitalizations. A 72-years-old male patient with arterial hypertension, poorly controlled T2DM, TIA and chronic kidney disease presented…